|
|
||||||||
Department of Nuclear Medicine, Rebecca Sieff Government Hospital, Safed
Departments of Nuclear Medicine and Urology, Rambam Medical Center, Haifa
Department of Nuclear Medicine, Nahariya Hospital, Nahariya
The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
Correspondence: For correspondence or reprints contact: David Groshar, MD, Dept. of Nuclear Medicine, Rebecca Sieff Government Hospital, 13100 Safed, Israel.
ABSTRACT
Quantitative SPECT was used to evaluate renal functional volume (cc), percent of injected dose/cc (%ID/cc) and renal uptake (%) in 11 children with unilateral vesicoureteral reflux grade 3 or greater, and in 19 normal control children without reflux. Methods: Studies were performed 46 hr after intravenous injection of 0.7502 mCi of 99mTc-DMSA. Results: Control kidneys (n = 38) had a volume of 99.7 ± 29.5 cc. The %ID/cc was 0.27 ± 0.08, and the uptake in one kidney was 24.8% ± 3.9%. Global renal uptake (right plus left) was 49.6% ± 7.3%. Functional volume of the control kidneys showed an increase with age, and the %ID/cc showed a steeper decrease with age, resulting in a trend of the kidney uptake to decrease with age. Kidneys with reflux had a decreased kidney uptake of 15.7% ± 29.5%, compared to age-and sex-matched controls (t = 4.7, p < 0.001). The contralateral kidneys without reflux had a significantly increased total uptake of 33.4% ± 6.8% as compared to controls (t = 3.44, p < 0.01). Global uptake by the kidneys was 49.2% ± 8.6% and was not statistically different from controls (t = 1.0, ns). Conclusion: Our results suggest that SPECT quantitation of 99mTc-DMSA uptake in each kidney separately could be used as a noninvasive method to assess impairment and compensation of the function of the individual kidney in children with vesicoureteral reflux.
Key Words: vesicoureteral reflux unilateral kidney disease technetium-99m-DMSA SPECT
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |